UAB clinical trial explores new ovarian cancer treatment approach
Up to 70 percent of women with high-grade ovarian cancer see their cancer return after surgery and platinum-based chemotherapy. A new clinical trial at the University of Alabama at Birmingham is testing an investigational treatment that could eventually offer a new way to fight the disease.